… Our finding that sleep apnoea correlated with glycaemic control and with duration of disease
appears to show that the ventilatory changes or autonomic nervous system dysfunction or …

… Our findings indicate that CPAP does not improve glycaemic control (indicated by HbA1c
level) or BMI but may improve insulin sensitivity in patients with OSA and T2DM. …

… obstructive sleep apnoea and diabetes. The potential effect of obstructive sleep apnoea on
… the development and progression of obstructive sleep apnoea. Thus, a major focus of this …

… This meta-analysis was designed to evaluate the effect of treatment of OSA with CPAP on
glycaemic control in patients with type 2 diabetes. We found that CPAP treatment did not alter …

… In conclusion, CPAP therapy significantly improved glycaemic control and insulin resistance
as shown by the decreased HbA1c levels, fasting glucose levels and HOMA-IR values in …

… between CPAP use and the measures of glycaemic control or insulin resistance. … controlled
trial using therapeutic and placebo CPAP to assess the effect of CPAP on glycaemic control (…

… Recently, varying day-to-day sleep schedules, ie sleep … This study explored whether sleep
variability affects glycaemic control … Sleep apnoea risk and self-reported sleep quality were …

… Obstructive sleep apnoea (OSA) is a very common medical condition that is associated with
… OSA is also associated with worse glycaemic control and vascular disease in patients with …

… Obstructive sleep apnoea (OSA) is a sleep-related breathing … sleep, leading to repetitive
oxygen desaturation and sleep … to achieve improvements in glycaemic control. One limitation …

… The conflicting results of these studies might be related to multiple factors including differences
in CPAP compliance, baseline glycaemic control and the reserve in β-cell function. Other …